Form 8-K - Current report:
SEC Accession No. 0001104659-24-109439
Filing Date
2024-10-17
Accepted
2024-10-17 11:50:50
Documents
67
Period of Report
2024-10-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2426322d1_8k.htm   iXBRL 8-K 26230
2 EXHIBIT 99.1 tm2426322d1_ex99-1.htm EX-99.1 27626
3 EXHIBIT 99.2 tm2426322d1_ex99-2.htm EX-99.2 61777
4 EXHIBIT 99.3 tm2426322d1_ex99-3.htm EX-99.3 32067
8 GRAPHIC tm2426322d1_ex99-1img001.jpg GRAPHIC 235385
9 GRAPHIC tm2426322d1_ex99-1img002.jpg GRAPHIC 124081
10 GRAPHIC tm2426322d1_ex99-1img003.jpg GRAPHIC 207661
11 GRAPHIC tm2426322d1_ex99-1img004.jpg GRAPHIC 261720
12 GRAPHIC tm2426322d1_ex99-1img005.jpg GRAPHIC 262925
13 GRAPHIC tm2426322d1_ex99-1img006.jpg GRAPHIC 254909
14 GRAPHIC tm2426322d1_ex99-1img007.jpg GRAPHIC 256522
15 GRAPHIC tm2426322d1_ex99-1img008.jpg GRAPHIC 258843
16 GRAPHIC tm2426322d1_ex99-1img009.jpg GRAPHIC 170431
17 GRAPHIC tm2426322d1_ex99-1img010.jpg GRAPHIC 132070
18 GRAPHIC tm2426322d1_ex99-1img011.jpg GRAPHIC 225666
19 GRAPHIC tm2426322d1_ex99-1img012.jpg GRAPHIC 152154
20 GRAPHIC tm2426322d1_ex99-1img013.jpg GRAPHIC 156178
21 GRAPHIC tm2426322d1_ex99-1img014.jpg GRAPHIC 215669
22 GRAPHIC tm2426322d1_ex99-1img015.jpg GRAPHIC 313680
23 GRAPHIC tm2426322d1_ex99-3img001.jpg GRAPHIC 4327
24 GRAPHIC tm2426322d1_ex99-2img001.jpg GRAPHIC 179472
25 GRAPHIC tm2426322d1_ex99-2img002.jpg GRAPHIC 519374
26 GRAPHIC tm2426322d1_ex99-2img003.jpg GRAPHIC 153459
27 GRAPHIC tm2426322d1_ex99-2img004.jpg GRAPHIC 117344
28 GRAPHIC tm2426322d1_ex99-2img005.jpg GRAPHIC 284223
29 GRAPHIC tm2426322d1_ex99-2img006.jpg GRAPHIC 170679
30 GRAPHIC tm2426322d1_ex99-2img007.jpg GRAPHIC 259379
31 GRAPHIC tm2426322d1_ex99-2img008.jpg GRAPHIC 324439
32 GRAPHIC tm2426322d1_ex99-2img009.jpg GRAPHIC 249528
33 GRAPHIC tm2426322d1_ex99-2img010.jpg GRAPHIC 265635
34 GRAPHIC tm2426322d1_ex99-2img011.jpg GRAPHIC 248356
35 GRAPHIC tm2426322d1_ex99-2img012.jpg GRAPHIC 196990
36 GRAPHIC tm2426322d1_ex99-2img013.jpg GRAPHIC 198396
37 GRAPHIC tm2426322d1_ex99-2img014.jpg GRAPHIC 178640
38 GRAPHIC tm2426322d1_ex99-2img015.jpg GRAPHIC 156906
39 GRAPHIC tm2426322d1_ex99-2img016.jpg GRAPHIC 169749
40 GRAPHIC tm2426322d1_ex99-2img017.jpg GRAPHIC 186398
41 GRAPHIC tm2426322d1_ex99-2img018.jpg GRAPHIC 273713
42 GRAPHIC tm2426322d1_ex99-2img019.jpg GRAPHIC 179333
43 GRAPHIC tm2426322d1_ex99-2img020.jpg GRAPHIC 201848
44 GRAPHIC tm2426322d1_ex99-2img021.jpg GRAPHIC 180953
45 GRAPHIC tm2426322d1_ex99-2img022.jpg GRAPHIC 209393
46 GRAPHIC tm2426322d1_ex99-2img023.jpg GRAPHIC 218835
47 GRAPHIC tm2426322d1_ex99-2img024.jpg GRAPHIC 255717
48 GRAPHIC tm2426322d1_ex99-2img025.jpg GRAPHIC 165001
49 GRAPHIC tm2426322d1_ex99-2img026.jpg GRAPHIC 260538
50 GRAPHIC tm2426322d1_ex99-2img027.jpg GRAPHIC 211247
51 GRAPHIC tm2426322d1_ex99-2img028.jpg GRAPHIC 259076
52 GRAPHIC tm2426322d1_ex99-2img029.jpg GRAPHIC 223226
53 GRAPHIC tm2426322d1_ex99-2img030.jpg GRAPHIC 214110
54 GRAPHIC tm2426322d1_ex99-2img031.jpg GRAPHIC 116752
55 GRAPHIC tm2426322d1_ex99-2img032.jpg GRAPHIC 284308
56 GRAPHIC tm2426322d1_ex99-2img033.jpg GRAPHIC 290353
57 GRAPHIC tm2426322d1_ex99-2img034.jpg GRAPHIC 213650
58 GRAPHIC tm2426322d1_ex99-2img035.jpg GRAPHIC 102754
  Complete submission text file 0001104659-24-109439.txt   15459626

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vstm-20241017.xsd EX-101.SCH 3015
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vstm-20241017_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vstm-20241017_pre.xml EX-101.PRE 22359
69 EXTRACTED XBRL INSTANCE DOCUMENT tm2426322d1_8k_htm.xml XML 3675
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35403 | Film No.: 241376596
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)